Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$12.64 -0.56 (-4.24%)
As of: Oct 22, 2026 · 1:34 PM EDT

Eloxx Pharmaceuticals (ELOX) Restructuring Costs (2018 - 2020)

Updated

Eloxx Pharmaceuticals (ELOX) reported Restructuring Costs of $24,000 for Q4 2020, down 98.7% from the prior quarter.

Analysis

Eloxx Pharmaceuticals (ELOX) Restructuring Costs (2018 - 2020) Analysis & Trends

For FY2020, Eloxx Pharmaceuticals posted Restructuring Costs of $1.89 million.

  • The Q4 2020 figure ranks as the lowest quarterly Restructuring Costs since Q2 2018.
  • Per Business Quant data, the three quarters before Q4 2020 came in at $1.87 million (Q3 2020), $1.87 million (Q2 2020) and $1.87 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,169.89 Bn 1,138.48 Bn 19.71 Bn
2 Johnson & Johnson 648.35 Bn 568.21 Bn 17.30 Bn
3 AbbVie 504.24 Bn 477.35 Bn 12.70 Bn
4 Merck 365.96 Bn 320.33 Bn 12.21 Bn
5 Novartis Ag 303.28 Bn 267.27 Bn 11.24 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn
7 Amgen 242.76 Bn 198.16 Bn 7.24 Bn
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn
9 Pfizer 172.99 Bn 119.64 Bn 10.94 Bn
10 Eloxx Pharmaceuticals 85.82 Mn 12.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 24,000.00
Sep 30, 2020 1.87 Mn
Jun 30, 2020 1.87 Mn
Mar 31, 2020 1.87 Mn
Jun 30, 2018 -1.30 Mn
Mar 31, 2018 761,000.00
API Access

Eloxx Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ELOX&period=max&api_key=YOUR_API_KEY